United States:
Why Broad Functional Patent Claims Suppress Medical Innovation
11 January 2023
Kramer Levin Naftalis & Frankel LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Head of Life Sciences Irena Royzman authored a Bloomberg
Law article titled "Why Broad Functional Patent Claims
Suppress Medical Innovation" on Jan. 9, 2023. The article
analyzes broad functional patent claims of biologic materials and
how a current US Supreme Court case could have a major impact on
drug development and other areas of innovation.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.
